Illumicell AI
Advanced AI and space technology redefining fertility care for streamlined clinical operations and accelerated business growth.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
* | $2.0m | Seed | |
| Total Funding | 000k | ||
Related Content
Illumicell AI leverages advanced artificial intelligence and space technology to revolutionize fertility care. The company focuses on streamlining clinical operations, accelerating business growth, and delivering value to patients. Operating in the healthcare sector, Illumicell AI primarily serves fertility clinics and healthcare providers. Its business model revolves around offering AI-driven solutions that enhance the efficiency and effectiveness of fertility treatments. Revenue is generated through subscription-based services and partnerships with healthcare institutions. The company has garnered attention by joining prestigious programs like the Harvard LLX GEO 2023-2024 cohort and the Techstars DeepTech accelerator, and being recognized as a TechCrunch Disrupt 200 startup.
Keywords: AI, space technology, fertility care, clinical operations, business growth, healthcare, fertility clinics, subscription services, partnerships, innovation.